Total Payments
$1,391
2024 Payments
$33.98
Companies
20
Transactions
87
Medicare Patients
850
Medicare Billing
$480,484
Payment Breakdown by Category
Food & Beverage$1,386 (99.6%)
Education$5.00 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,386 | 86 | 99.6% |
| Education | $5.00 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $269.93 | 15 | $0 (2018) |
| Novo Nordisk Inc | $212.94 | 12 | $0 (2018) |
| Allergan Inc. | $150.35 | 13 | $0 (2018) |
| Astellas Pharma US Inc | $130.60 | 9 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $113.60 | 7 | $0 (2018) |
| ABBVIE INC. | $100.36 | 4 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $70.59 | 4 | $0 (2018) |
| GlaxoSmithKline, LLC. | $51.71 | 3 | $0 (2018) |
| Takeda Pharmaceuticals America, Inc. | $41.47 | 3 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $39.92 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33.98 | 1 | ABBVIE INC. ($33.98) |
| 2022 | $16.64 | 1 | ABBVIE INC. ($16.64) |
| 2021 | $49.74 | 2 | AbbVie Inc. ($49.74) |
| 2018 | $564.61 | 35 | Novo Nordisk Inc ($128.37) |
| 2017 | $725.81 | 48 | AstraZeneca Pharmaceuticals LP ($150.04) |
All Payment Transactions
87 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/05/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $33.98 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/21/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $28.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/01/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: Neuroscience | ||||||
| 10/30/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.36 | General |
| Category: Cardiovascular | ||||||
| 10/29/2018 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/09/2018 | PFIZER INC. | VIAGRA (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 10/02/2018 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: VACCINES | ||||||
| 09/26/2018 | GlaxoSmithKline, LLC. | ADVAIR (Drug), FLOVENT | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: RESPIRATORY | ||||||
| 09/24/2018 | Allergan Inc. | BYSTOLIC (Drug) | Food and Beverage | In-kind items and services | $11.87 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/20/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $1.49 | General |
| Category: Diabetes | ||||||
| 09/19/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Diabetes | ||||||
| 09/06/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: UROLOGY | ||||||
| 08/16/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Central Nervous System (CNS) | ||||||
| 08/07/2018 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.24 | General |
| 07/19/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: DIABETES | ||||||
| 07/16/2018 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.58 | General |
| 07/09/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: UROLOGY | ||||||
| 07/02/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/26/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: DIABETES | ||||||
| 06/17/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: UROLOGY | ||||||
| 06/05/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Diabetes | ||||||
| 06/04/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 157 | 781 | $352,564 | $107,362 |
| 2022 | 4 | 225 | 854 | $398,202 | $119,350 |
| 2021 | 5 | 240 | 909 | $425,669 | $131,793 |
| 2020 | 5 | 228 | 835 | $389,351 | $121,979 |
Total Patients
850
Total Services
3,379
Medicare Billing
$480,484
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 88 | 693 | $332,640 | $101,764 | 30.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 38 | 57 | $8,550 | $2,408 | 28.2% |
| 99345 | Residence visit for new patient with high level of medical decision making, per day, if using time, at least 75 minutes | Office | 2023 | 12 | 12 | $7,080 | $1,965 | 27.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 19 | 19 | $4,294 | $1,224 | 28.5% |
| 99337 | Established patient custodial care facility, group care, or assisted living visit, typically 1 hour | Office | 2022 | 105 | 705 | $360,960 | $108,303 | 30.0% |
| 99328 | New patient custodial care facility, group care, or assisted living visit, typically 75 minutes | Office | 2022 | 28 | 28 | $16,128 | $4,700 | 29.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 56 | 82 | $12,300 | $3,628 | 29.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 36 | 39 | $8,814 | $2,719 | 30.8% |
| 99337 | Established patient assisted living visit, typically 60 minutes | Office | 2021 | 102 | 749 | $383,488 | $118,300 | 30.8% |
| 99328 | New patient assisted living visit, typically 75 minutes | Office | 2021 | 32 | 32 | $18,432 | $5,653 | 30.7% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 63 | 82 | $12,300 | $3,629 | 29.5% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 30 | 33 | $7,458 | $2,388 | 32.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 13 | 13 | $3,991 | $1,822 | 45.7% |
| 99337 | Established patient assisted living visit, typically 60 minutes | Office | 2020 | 102 | 677 | $346,624 | $108,699 | 31.4% |
| 99328 | New patient assisted living visit, typically 75 minutes | Office | 2020 | 30 | 30 | $17,280 | $5,512 | 31.9% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 59 | 82 | $12,300 | $3,713 | 30.2% |
| 99336 | Established patient assisted living visit, typically 40 minutes | Office | 2020 | 15 | 21 | $7,497 | $2,249 | 30.0% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 22 | 25 | $5,650 | $1,806 | 32.0% |
About Dr. Devendra Shah, M.D
Dr. Devendra Shah, M.D is a Internal Medicine healthcare provider based in Elgin, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700952140.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Devendra Shah, M.D has received a total of $1,391 in payments from pharmaceutical and medical device companies, with $33.98 received in 2024. These payments were reported across 87 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,386).
As a Medicare-enrolled provider, Shah has provided services to 850 Medicare beneficiaries, totaling 3,379 services with total Medicare billing of $480,484. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Elgin, IL
- Active Since 11/28/2006
- Last Updated 03/07/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700952140
Products in Payments
- LINZESS (Drug) $127.94
- FARXIGA (Drug) $119.01
- MYRBETRIQ (Drug) $87.74
- BYDUREON (Drug) $75.94
- TRADJENTA (Drug) $58.87
- Victoza (Drug) $46.30
- Xultophy 100/3.6 (Drug) $42.88
- Myrbetriq (Drug) $42.86
- SOLIQUA (Drug) $42.27
- Saxenda (Drug) $40.43
- ENTRESTO (Drug) $39.92
- ADVAIR (Drug) $36.21
- CREON (Drug) $33.98
- XARELTO (Drug) $33.09
- SYMBICORT (Drug) $32.90
- JARDIANCE (Drug) $32.10
- VIBERZI (Drug) $31.93
- Trintellix (Drug) $30.29
- BEVESPI AEROSPHERE (Drug) $29.32
- TOUJEO (Drug) $28.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Elgin
Mr. Michael Hernandez, M.d, M.D
Internal Medicine — Payments: $26,674
Internal Medicine $26,674
Dr. Robert Tiballi, D.o, D.O
Internal Medicine — Payments: $20,485
Internal Medicine $20,485
Paula Belmar, Md, MD
Internal Medicine — Payments: $12,301
Internal Medicine $12,301
Dr. Heena Shyamani, M.d, M.D
Internal Medicine — Payments: $12,014
Internal Medicine $12,014
Mr. Richard Baley, M.d, M.D
Internal Medicine — Payments: $11,178
Internal Medicine $11,178
John Adams, Md, MD
Internal Medicine — Payments: $10,883
Internal Medicine $10,883